2016-01202. Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc.  

  • Start Preamble

    ACTION:

    Notice of application.

    DATES:

    Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before March 21, 2016.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section 7 of 28 CFR part 0, appendix to subpart R.

    In accordance with 21 CFR 1301.33(a), this is notice that on September 3, 2015, Johnson Matthey, Inc., Pharmaceuticals Materials, 900 River Road, Conshohocken, Pennsylvania 19428 applied to be Start Printed Page 3476registered as a bulk manufacturer of the following basic classes of controlled substances:

    Controlled substanceSchedule
    Gamma Hydroxybutyric Acid (2010)I
    Amphetamine (1100)II
    Methylphenidate (1724)II
    Codeine (9050)II
    Oxycodone (9143)II
    Diphenoxylate (9170)II
    Hydrocodone (9193)II
    Meperidine (9230)II
    Methadone (9250)II
    Methadone intermediate (9254)II
    Morphine (9300)II
    Thebaine (9333)II

    The company plans to manufacture the listed controlled substances in bulk for distribution and sale to its customers. The thebaine (9333) will be used to manufacture other controlled substances for sale in bulk to its customers.

    Start Signature

    Dated: January 13, 2016.

    Louis J. Milione,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2016-01202 Filed 1-20-16; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
01/21/2016
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2016-01202
Dates:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before March 21, 2016.
Pages:
3475-3476 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2016-01202.pdf